People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Pharmaceuticals, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eyegate Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $72.9M | $92.6M | 2009 |
| Vicarious Surgical Inc. | — | Medical Devices | Series B | $55.9M | $51.2M | 2025 |
Stephen From at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen From on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sarah Romano | 2 | 3 |
| Samir Kaul | 1 | 32 |
| DROR BERMAN | 1 | 8 |
| Praveen Tyle | 1 | 5 |
| Ric Fulop | 1 | 4 |
| Beverly Huss | 1 | 4 |
| Eric Daniels | 1 | 4 |
| Steven Boyd | 1 | 3 |
| Neil Devani | 1 | 3 |
| Barry Greene | 1 | 3 |
| Thomas E. Hancock | 1 | 3 |
| David Hollander | 1 | 3 |
| Peter Greenleaf | 1 | 3 |
| David Ho | 1 | 2 |
| Adam Sachs | 1 | 2 |
| Joseph Doherty | 1 | 2 |
| Paul Chaney | 1 | 2 |
| Bernard Malfroy-Camine | 1 | 2 |
| Victoria Carr-Brendel | 1 | 2 |
| J. Sebastien Cleiftie | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.